Who
Pierre Kyme
Chief Business Officer
Company insider
Files Form 4 as: Chief Business Officer, Armata Pharmaceuticals.
In numbers
- Trades disclosed
- 6
- Buys
- 0
- Sells
- 0
- Bought
- $0
- Sold
- $0
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 5 Feb 2025
- Last trade
- 14 Mar 2026
- Last filed
- 17 Mar 2026
Companies traded
Activity over time
Not enough dated trades to draw.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 14 Mar 2026filed 17 Mar 2026 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $11K1,030 at $10.54 | filing |
| 14 Mar 2026filed 17 Mar 2026 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $11K1,030 at $10.54 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —183,142 at $0.00 | filing |
| 9 Mar 2026filed 11 Mar 2026 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —183,142 at $0.00 | filing |
| 14 Mar 2025filed 25 Apr 2025 | ARMP Armata PharmaceuticalsBiotechnology | SEC FORM 4 Code F | $2,0031,027 at $1.95 | filing |
| 5 Feb 2025filed 7 Feb 2025 | ARMP Armata Pharmaceuticalsoption or derivative · Biotechnology | SEC FORM 4 Code A | —100,000 at $0.00 | filing |
News
No headline names them, or the companies they trade most, lately.
Sectors
No trade we could place in a sector.